These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19483162)

  • 1. Detection of continuous erythropoietin receptor activator in blood and urine in anti-doping control.
    Lasne F; Martin L; Martin JA; de Ceaurriz J
    Haematologica; 2009 Jun; 94(6):888-90. PubMed ID: 19483162
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant erythropoietin in urine.
    Lasne F; de Ceaurriz J
    Nature; 2000 Jun; 405(6787):635. PubMed ID: 10864311
    [No Abstract]   [Full Text] [Related]  

  • 3. Procedures for monitoring recombinant erythropoietin and analogues in doping control.
    Segura J; Pascual JA; Gutiérrez-Gallego R
    Anal Bioanal Chem; 2007 Aug; 388(7):1521-9. PubMed ID: 17516052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-throughput test to detect C.E.R.A. doping in blood.
    Lamon S; Giraud S; Egli L; Smolander J; Jarsch M; Stubenrauch KG; Hellwig A; Saugy M; Robinson N
    J Pharm Biomed Anal; 2009 Dec; 50(5):954-8. PubMed ID: 19625154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood test may help discourage doping.
    Expert Rev Mol Diagn; 2002 Mar; 2(2):95. PubMed ID: 11962345
    [No Abstract]   [Full Text] [Related]  

  • 6. Sensitivity and specificity of detection methods for erythropoietin doping in cyclists.
    Heuberger JAAC; van Eenoo P; Rotmans JI; Gal P; Stuurman FE; Post TE; Daniels JMA; Ram H; de Hon O; Burggraaf J; Cohen AF
    Drug Test Anal; 2019 Sep; 11(9):1290-1301. PubMed ID: 31232530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters.
    Dehnes Y; Hemmersbach P
    Drug Test Anal; 2011 May; 3(5):291-9. PubMed ID: 21387570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive?
    Lippi G; Franchini M; Guidi G
    Haematologica; 2004 Apr; 89(4):ELT05. PubMed ID: 15075118
    [No Abstract]   [Full Text] [Related]  

  • 9. GASepo-a software solution for quantitative analysis of digital images in Epo doping control.
    Bajla I; Holländer I; Minichmayr M; Gmeiner G; Reichel Ch
    Comput Methods Programs Biomed; 2005 Dec; 80(3):246-70. PubMed ID: 16260062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to confirm C.E.R.A. doping in athletes' blood?
    Leuenberger N; Lamon S; Robinson N; Giraud S; Saugy M
    Forensic Sci Int; 2011 Dec; 213(1-3):101-3. PubMed ID: 21889277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and blood doping.
    Robinson N; Giraud S; Saudan C; Baume N; Avois L; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i30-4. PubMed ID: 16799100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the instability of the isoelectric focusing patterns of erythropoietin in urine.
    Belalcazar V; Gutiérrez Gallego R; Llop E; Segura J; Pascual JA
    Electrophoresis; 2006 Nov; 27(22):4387-95. PubMed ID: 17054082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sports drug testing for erythropoiesis-stimulating agents and autologous blood transfusion.
    Reichel C
    Drug Test Anal; 2012 Nov; 4(11):803-4. PubMed ID: 22927317
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimizing SAR-PAGE.
    Reihlen P; Blobel M; Kempkes R; Reichel C; Völker Schänzer E; Majer B; Schänzer W
    Drug Test Anal; 2015; 7(11-12):1014-6. PubMed ID: 26607413
    [No Abstract]   [Full Text] [Related]  

  • 15. "Genetic Doping" with erythropoietin cDNA in primate muscle is detectable.
    Lasne F; Martin L; de Ceaurriz J; Larcher T; Moullier P; Chenuaud P
    Mol Ther; 2004 Sep; 10(3):409-10. PubMed ID: 15336641
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent developments in doping testing for erythropoietin.
    Reichel C
    Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry.
    Yu NH; Ho EN; Wan TS; Wong AS
    Anal Bioanal Chem; 2010 Apr; 396(7):2513-21. PubMed ID: 20148243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control.
    Reichel C; Kulovics R; Jordan V; Watzinger M; Geisendorfer T
    Drug Test Anal; 2009 Jan; 1(1):43-50. PubMed ID: 20355158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARCOSYL-PAGE: Optimized Protocols for the Separation and Immunological Detection of PEGylated Proteins.
    Reichel C; Gmeiner G; Reihlen P; Thevis M; Schänzer W
    Methods Mol Biol; 2019; 1855():131-149. PubMed ID: 30426415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug testing at the Sydney Olympics.
    Corrigan B; Kazlauskas R
    Med J Aust; 2000 Sep; 173(6):312-3. PubMed ID: 11061402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.